eli lilly tirzepatide - Search News

Cipla, India and Eli Lilly

The Pharma Letter · 14h

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli Lilly to promote tirzepatide under the brand name Yurpeak in India.

Continue reading

· 2d · on MSN

Eli Lilly allows Cipla to sell weight loss drug under new brand in India

Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say

2d

Newsbreak Confirmed: What to make of Cipla's Yurpeak pact with Eli Lilly? Nuvama raises target by Rs 74

Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...

3don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results